BeyondSpring Inc.
Pharmaceutical company · Florham Park, New Jersey, United States · Nasdaq: BYSI
BeyondSpring Inc. is a pharmaceutical company headquartered in Florham Park, New Jersey, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker BYSI. It has reported private securities offerings to the US SEC, most recently $7.2 million sold in a notice filed in 2017.
BeyondSpring at a glance
What does BeyondSpring do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7.2 million sold (2017).
Frequently asked questions about BeyondSpring
Where is BeyondSpring headquartered?
BeyondSpring Inc. is headquartered in Florham Park, New Jersey, United States.
What does BeyondSpring do?
BeyondSpring Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is BeyondSpring a public company?
Yes. BeyondSpring Inc. trades on Nasdaq under the ticker BYSI.
When was BeyondSpring founded?
The earliest incorporation on record for BeyondSpring Inc. is in 2014, according to public company registers.
Similar companies
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Celularity IncFlorham Park, New Jersey, United States
- Phathom Pharmaceuticals, Inc.Florham Park, New Jersey, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences